What's in Radiomedix, Inc.'s pipeline?

Radiomedix, Inc. has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Radiomedix, Inc.'s portfolio?

Top competitors by shared drug class: Clarity Pharmaceuticals Ltd, Teva Branded Pharmaceutical Products R&D, Inc., UMC Utrecht, University of Colorado, Denver, University of Saskatchewan.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/radiomedix-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Radiomedix, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Radiomedix, Inc. pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
64Cu-DOTATATE	64Cu-DOTATATE	phase 3	Radiopharmaceutical; PET imaging agent	Somatostatin receptor 2 (SSTR2)	Oncology; Diagnostic Imaging

Therapeutic area mix

Oncology; Diagnostic Imaging · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Clarity Pharmaceuticals Ltd · 1 shared drug class
Teva Branded Pharmaceutical Products R&D, Inc. · 1 shared drug class
UMC Utrecht · 1 shared drug class
University of Colorado, Denver · 1 shared drug class
University of Saskatchewan · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Radiomedix, Inc.:

Cite this brief

Drug Landscape (2026). Radiomedix, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/radiomedix-inc. Accessed 2026-05-16.